Diego Cortina de la Fuente, MD, M.Sc.

Sharpshooter
DISC Type : DC

Director Global Pipeline Value Evidence Strategy (MS, Rare Diseases, Neurodegeneration) at Biogen

Randolph, New Jersey, United States

Overview

Diego is a Global Advocacy and Market Access leader with over 15 years of experience maximizing patient access to critical drugs in oncology, hematology, and rare diseases. At Biogen, he leads value and evidence strategy for pipeline assets. He holds an MSc from The London School of Economics and Political Science.

Colleagues describe him as an approachable, empathetic, and results-driven leader. He is known for being a knowledgeable team player, generous with his time, and skilled at formally mentoring others. He is passionate about bringing critical therapies to patients and addressing healthcare inequalities.

For his professional achievements, he was honored for Excellence in Medicine and recognized as a Top Professional by Marquis Whos Who.

Personality Overview

Fast But Analytical

Rigorous & Demanding

Precise But Practical

They respond well to strong and respectful communication.  They like to move fast and expect the same from others. They take a lot of pride in personal achievements.

Topics They Care About

Patient Access Strategy
His career at Biogen, Novartis, and Bayer has centered on creating pricing and reimbursement strategies to ensure patient access to novel therapies across the globe.
Rare Disease Therapies
His current role at Biogen focuses on shaping the value strategy for pipeline assets in rare diseases, multiple sclerosis, and neurodegeneration.
Health Policy Shaping
He has a track record of partnering with policymakers to deliver policy changes that strengthen reimbursement frameworks, particularly during his time at Bayer.

Media Appearances

Diego has no verified media appearances

Work History

1-2023
Director Global Pipeline Value Evidence Strategy (MS, Rare Diseases, Neurodegeneration) at Biogen
8-2020 - 1-2023
Global Product Development and Commercialization Value and Access lead Fumarates and Interferons at Biogen
2-2016 - 4-2020
Market Access Hematology Franchise Lead - Latin America & Canada at Novartis
1-2011 - 1-2016
Global Advocacy Deputy Director at Bayer Health Care
2-2011 - 11-2013
Regional Market Access Deputy Director Latin America at Bayer Health Care

Education

2003 - 2004
MSc from The London School of Economics and Political Science (LSE)
2013 - 2014
post Graduate Di from Universidad Anáhuac

More Information

Social Presence :

Prographics :

Exp : 16 Location : Randolph, New Jersey, United States Job Level : Mid-senior Designation : Director Global Pipeline Value Evidence Strategy (MS, Rare Diseases, Neurodegeneration) at Biogen
URL has been copied!

Insights For Selling To Diego

During A Call Or A Meeting

DO's

  • Hold your ground without indulging in one-upmanship
  • Help them weigh the risks by sharing objective proof points without becoming too analytical
  • Be respectful but crisp

DONT's

  • Do not hesitate from asking counter questions, just avoid challenging their authority
  • Don’t be in a rush to invite them for a social meet and greet
  • Avoid being too verbose

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Diego is

  • Confidence in impact is paramount to them, followed by a sense of achievement and ROI.
  • Will you ever get a clear answer from Diego

  • If they decide not to go ahead, they will say no without hesitation.

Insights For Deal Planning

    How fast (or slow) will Diego move?

  • They can reach decisions fairly quickly if they are convinced.
  • Can Diego take some risk or not?

  • They don’t mind risks but can be quite binary about them.

You And Diego

Personality Compatibility


Other Biogen Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.